OMass Raises $310M Series C to Fund Clinical Development
Bain Capital Life Sciences, Forbion and Novo Holdings co-led OMass’s $310M Series C. The financing funds clinical milestones, not proven medicines.
Venture Capital News & Analysis
Funding news, venture capital analysis, investor profiles, and market intelligence.
-
-
Astribot Discloses RMB1B Financing at RMB15B Valuation
Astribot disclosed RMB1B of financing led by HTI Donghai at a reported RMB15B valuation. Announced October 13, the round reportedly closed in September.
-
AGIBOT Reportedly Seeks RMB1–1.5B at RMB50B Valuation
Caijing reports AGIBOT is nearing an RMB1–1.5B financing at about RMB50B. No close, investor syndicate, stage or final valuation is confirmed.
-
Infinigence AI Closes RMB2.3B Series C for Cross-Chip AI Infrastructure
Infinigence AI's RMB2.3B Series C backs heterogeneous computing and inference services. RMB4.3B is cumulative funding; the latest syndicate remains unclear.
-
Lanxin Computing Raises Nearly RMB2B Across B-Series Financings
Lanxin Computing disclosed nearly RMB2B across B-series financings for RISC-V server CPUs. The aggregate is not one separately itemized round.
-
Forgepoint Raises $9.8M Seed for AI Manufacturing Quotes
Primary Venture Partners and a16z speedrun lead Forgepoint's $9.8M seed round for Frank, an AI quoting agent that retains human commercial approvals.